Pancreatic adenocarcinoma

Margaret Tempero, Rameezs Alasadi, J. Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B. Benson, Pankaj Bhargava, John L. Cameron, Ephraim S. Casper, John P. Hoffman, Paula Kim, Wui Jin Koh, Boris Kuvshinoff, Mokenge P. Malafa, Peter Muscarella, Eric K. Nakakura, Aaron R. Sasson, Stephen Shibata, Dennis C. Shrieve, Mark TalamontiDouglas S. Tyler, Hanlin Wang, Robert S. Warren, Christopher Willett, Robert A. Wolff

Research output: Contribution to journalReview article

37 Scopus citations

Abstract

Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

Original languageEnglish (US)
Pages (from-to)998-1033
Number of pages36
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume5
Issue number10
StatePublished - Nov 1 2007

    Fingerprint

Keywords

  • Adenocarcinoma
  • Ductal carcinoma
  • Endoscopic retrograde cholangiopancreatography
  • Gemcitabine
  • NCCN clinical practice guidelines
  • Pancreas
  • Ultrasonography

ASJC Scopus subject areas

  • Oncology

Cite this

Tempero, M., Alasadi, R., Arnoletti, J. P., Behrman, S., Ben-Josef, E., Benson, A. B., Bhargava, P., Cameron, J. L., Casper, E. S., Hoffman, J. P., Kim, P., Koh, W. J., Kuvshinoff, B., Malafa, M. P., Muscarella, P., Nakakura, E. K., Sasson, A. R., Shibata, S., Shrieve, D. C., ... Wolff, R. A. (2007). Pancreatic adenocarcinoma. JNCCN Journal of the National Comprehensive Cancer Network, 5(10), 998-1033.